Furthermore, Nannipierri et al. [18] found that patients in remission of type 2 diabetes mellitus (T2DM) after MBS (RYGB and SG) had higher fasting GLP-1 levels as compared to patients not in remission. The gene discussed is GCG; the disease is type 2 diabetes mellitus.